Six Pillars of Our Technology Platform

Each capability is built on a foundation of proprietary data assets and custom-trained models, delivered as tailored solutions for each enterprise partner.

AI-Driven Target Identification

Deep learning models trained on multi-omic datasets surface high-confidence therapeutic targets with speed and precision, significantly reducing the early-discovery timeline. Our models integrate genomic, transcriptomic, and proteomic evidence layers to prioritize targets with the strongest disease association signals.

  • Multi-Omic Integration
  • Disease Association Scoring
  • Novel Target Discovery
  • Druggability Assessment

Computational Protein Design

Advanced generative models and molecular simulation capabilities for designing and optimizing biologic candidates with desired binding affinity, stability, and developability profiles. We leverage diffusion-based and language-model approaches to explore the vast sequence-structure landscape.

  • De Novo Antibody Design
  • Affinity Maturation
  • Stability Optimization
  • Developability Prediction

Bioinformatics & Multi-Omics Analytics

Scalable pipelines for processing and integrating genomics, transcriptomics, proteomics, and metabolomics data to uncover mechanistic insights and biomarker signatures. Our infrastructure handles petabyte-scale datasets with automated quality control and normalization.

  • Single-Cell Analysis
  • Spatial Transcriptomics
  • Pathway Enrichment
  • Biomarker Discovery

Proprietary Compute Infrastructure

Purpose-built training and inference clusters optimized for large-scale biological foundation models. Our dedicated GPU infrastructure delivers the computational throughput required for enterprise-grade AI workloads — from pre-training to fine-tuning and high-throughput inference.

  • Dedicated GPU Clusters
  • Foundation Model Training
  • High-Throughput Inference
  • Enterprise Security

Molecular Simulation & Docking

Physics-informed AI models for high-throughput virtual screening, binding affinity prediction, and molecular dynamics simulations. Our hybrid approach combines classical force-field methods with learned potentials for accuracy at scale.

  • Virtual Screening
  • Binding Free Energy
  • MD Simulations
  • ADMET Prediction

Custom Enterprise Pipelines

Each partner engagement begins with understanding your specific research goals. We architect bespoke computational workflows that integrate with your existing data infrastructure and R&D processes, ensuring seamless adoption and maximum impact.

  • Bespoke Workflows
  • API Integration
  • Data Pipeline Engineering
  • Continuous Optimization

End-to-End AI-Powered Discovery

From raw biological data to optimized therapeutic candidates — our integrated pipeline accelerates every stage of the discovery process.

Data Ingestion
Multi-omic data processing & QC
→
Target ID
AI-powered target prioritization
→
Hit Finding
Virtual screening & docking
→
Lead Optimization
Generative design & affinity maturation
→
Candidate
Developability & safety profiling

Built on Proprietary Data Assets

Our AI models are trained on curated, high-quality biological datasets spanning multiple modalities — combined with each partner's proprietary data under strict security protocols.

Multi-Petabyte
Curated Biological Data
Multi-Modal
Data Types Integrated
Dedicated
GPU Training Clusters
Enterprise
Data Security Standards